Notably, although not required, the assay has been used across multiple pre-clinical studies of different gene therapy development for immunodeficiencies to assess the transforming potential of the newly developed lentiviral vectors such as X-linked SCID [9], Artemis SCID [12] or RAG1 SCID [54]. Here, RAG1 is linked to immunodeficiency disease.